Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Rothbart SB, Dickson BM, Raab JR, Grzybowski AT, Krajewski K, Guo AH, et al. An Interactive Database for the Assessment of Histone Antibody Specificity. Mol Cell. 2015;59(3):502-11.

Drandi D, Kubiczkova-Besse L, Ferrero S, Dani N, Passera R, Mantoan B, et al. Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR. J Mol Diagn. 2015;17(6):652-60.

Pagan JK, Marzio A, Jones MJ, Saraf A, Jallepalli PV, Florens L, et al. Degradation of Cep68 and PCNT cleavage mediate Cep215 removal from the PCM to allow centriole separation, disengagement and licensing. Nat Cell Biol. 2015;17(1):31-43.

Labbé DP, Zadra G, Ebot EM, Mucci LA, Kantoff PW, Loda M, et al. Role of diet in prostate cancer: the epigenetic link. Oncogene. 2015;34(36):4683-91.

Mohamed A, Ayman A, Deniece J, Wang T, Kovach C, Siddiqui MT, et al. P62/Ubiquitin IHC Expression Correlated with Clinicopathologic Parameters and Outcome in Gastrointestinal Carcinomas. Front Oncol. 2015;5:70.

Rabadan R, Inghirami G. JAK-STAT in lymphoproliferative disorders. Oncoscience. 2015;2(9):737-8.

Martin NE, Gerke T, Sinnott JA, Stack EC, Andrén O, Andersson S-, et al. Measuring PI3K Activation: Clinicopathologic, Immunohistochemical, and RNA Expression Analysis in Prostate Cancer. Mol Cancer Res. 2015;13(10):1431-40.

Gkrouzman E, Kirou KA, Seshan SV, Chevalier JM. Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus. Case Rep Nephrol. 2015;2015:987212.

Ginter PS, Petrova K, Hoda SA. The grossly "rusty" tumor of breast: invasive ductal carcinoma with osteoclast-like giant cells. Int J Surg Pathol. 2015;23(1):32-3.

Kim D-, Hwang I, Muller FL, Paik J-. Functional regulation of FoxO1 in neural stem cell differentiation. Cell Death Differ. 2015;22(12):2034-45.